Searched for
LUPIN USFDA NOD
Lupin shares gain 2% after USFDA approval for HIV drugLupin's shares surged by 2.2% following tentative U.S. FDA approval for its generic HIV treatment, Bictegravir, Emtricitabine, and Tenofovi...- Lupin gets USFDA nod for generic HIV drugLupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at Lupin's Nagpur ...
- Lupin gets USFDA nod for generic medicationIndian drug maker Lupin has received tentative approval from the US Food and Drug Administration (FDA) to market a generic medication used ...
- Lupin gets USFDA nod to market generic drugThe company has received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Vigabatri...
- Lupin gains on USFDA nod to market Sevelamer CarbonateAccording to data for September 2021 released by IQVIA MAT September, Sevelamer Carbonate for oral suspension had estimated annual sales of...
- Lupin gets tentative nod from USFDA to market generic Brexpiprazole tabletsThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Brexpiprazole tab...
- Lupin gets USFDA nod to market generic HIV drugThe company has received approval from the United States Food and Drug Administration (USFDA) to market its Emtricitabine and Tenofovir Dis...
- Lupin gets USFDA nod to market generic Sevelamer Carbonate tabletsThe product is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on...
- Lupin gets tentative nod from USFDA for its toenail fungus treatment topical solutionThe company has received tentative approval to market its Efinaconazole topical solution, 10%, from the United States Food and Drug Adminis...
- Lupin, Cipla, Aurobindo dogged by USFDA hurdles: Surajit Pal, Prabhudas LilladherThe turnaround time will be different for different companies depending on complexity of issues.
- Lupin gets final USFDA nod for Mylan's skin disease creamThe approval is for multiple strengths of 0.025 per cent, 0.1 per cent and 0.5 per cent triamcinolone acetonide cream, said the company.
- Lupin gets USFDA nod for pitavastatinThe firm has received tentative approval from United States Food and Drug Administration to market its Pitavastatin tablets in the strength...
- Lupin launches generic oral contraceptive tablets in USThe USFDA had earlier given approval to market a generic version of Janssen Pharmaceuticals, Inc.'s Ortho Tri-Cyclen tablets in the same st...
- Lupin launches generic Aricept tablets in US marketLupin's product is a generic version of Eisai Inc's Aricept tablets which is indicated for the treatment of dementia of the Alzheimer's typ...
- Lupin gets USFDA nod for generic oral contraceptive tabletsLupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt.
- Lupin gets USFDA nod to market generic anti-epilepsy drugDrug maker Lupin today said it has received final approval from the US health regulator to market a generic version of UCB's Keppra Oral So...
- Lupin gets USFDA nod for anti-bacterial tablet"Levaquin tablets had annual sales of approximately USD 1.6 billion for the twelve months ended March, 2011, based on IMS Health sales data...
- Lupin gets USFDA nod for TrandolaprilLupin Ltd on Thursday said it has received US Food and Drug Administration (USFDA) approval for multiple strengths of Trandolapril Tablets ...
- Lupin gets USFDA nod for CefdinirPharmaceutical company Lupin has received US Food and Drug Administration (FDA) approval for its antibiotic drug Cefdinir for oral suspensi...
- Pharma cos unfazed by US regulatory hurdlesNotwithstanding litigation from innovator companies and regulatory reversals, the US continues to be the fertile ground for Indian pharmace...
Load More
